Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 2/20 | 0.38 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17055137 | 1.00 | SMN1; SMN2 (0.40) | SMN1; SMN2RAB9AALDH1A1POLBPKM | |
| SCHEMBL1747739 | 0.82 | POLB (0.43) | SMN1; SMN2RAB9AALDH1A1POLBPKM | |
| SCHEMBL25180529 | 0.81 | NNMT (0.46) | SMN1; SMN2RAB9AALDH1A1POLBNPC1 | |
| SCHEMBL30474590 | 0.81 | NNMT (0.46) | SMN1; SMN2RAB9AALDH1A1POLBNPC1 | |
| SCHEMBL473478 | 0.78 | L3MBTL1 (0.49) | ALDH1A1SLC6A2SLC6A4SLC6A3L3MBTL1 | |
| SCHEMBL4013605 | 0.75 | L3MBTL1 (0.46) | SMN1; SMN2RAB9AALDH1A1NPC1CYP2D6 | |
| SCHEMBL11564445 | 0.74 | SLC6A3 (0.46) | ALDH1A1SLC6A4SLC6A3KMT2A | |
| SCHEMBL28989765 | 0.74 | TRPA1 (0.45) | SMN1; SMN2ALDH1A1POLBPKMGAA | |
| SCHEMBL22230007 | 0.74 | L3MBTL1 (0.39) | SMN1; SMN2RAB9AALDH1A1POLBPKM | |
| SCHEMBL30977134 | 0.74 | L3MBTL1 (0.39) | SMN1; SMN2RAB9AALDH1A1POLBPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357265-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2023-11-09 | — | — | US | disclosed |
| US-20230357265-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2023-11-09 | — | — | US | disclosed |
| US-20230357265-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2023-11-09 | — | — | US | disclosed |
| EP-4214213-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | Prelude Therapeutics, Incorporated (US) | 2023-07-26 | — | — | EP | disclosed |
| US-11685744-B2 | CDK inhibitors and their use as pharmaceuticals | PRELUDE THERAPEUTICS INCORPORATED (US) | 2023-06-27 | — | — | US | disclosed |
| US-11685744-B2 | CDK inhibitors and their use as pharmaceuticals | PRELUDE THERAPEUTICS INCORPORATED (US) | 2023-06-27 | — | — | US | disclosed |
| US-11685744-B2 | CDK inhibitors and their use as pharmaceuticals | PRELUDE THERAPEUTICS INCORPORATED (US) | 2023-06-27 | — | — | US | disclosed |
| WO-2022061273-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2022-03-24 | — | — | WO | disclosed |
| WO-2022061273-A1 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | PRELUDE THERAPEUTICS, INCORPORATED (US) | 2022-03-24 | — | — | WO | disclosed |
| US-20220089608-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | PRELUDE THERAPEUTICS, INCORPORATED | 2022-03-24 | — | — | US | disclosed |
| US-20090318466-A1 | COMPOUNDS USEFUL AS PESTICIDES | DOW AGROSCIENCES LLC (US) | 2009-12-24 | — | — | US | disclosed |
| US-20090318466-A1 | COMPOUNDS USEFUL AS PESTICIDES | DOW AGROSCIENCES LLC (US) | 2009-12-24 | — | — | US | disclosed |
| US-20090318466-A1 | COMPOUNDS USEFUL AS PESTICIDES | DOW AGROSCIENCES LLC (US) | 2009-12-24 | — | — | US | disclosed |
| US-7557132-B2 | Compounds useful as pesticides | DOW AGROSCIENCES LLC (US) | 2009-07-07 | — | — | US | disclosed |
| US-7557132-B2 | Compounds useful as pesticides | DOW AGROSCIENCES LLC (US) | 2009-07-07 | — | — | US | disclosed |
| US-7557132-B2 | Compounds useful as pesticides | DOW AGROSCIENCES LLC (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1572656-A4 | COMPOUNDS USEFUL AS PESTICIDES | DOW AGROSCIENCES LLC (US) | 2006-09-06 | — | — | EP | disclosed |
| US-20060063741-A1 | Compounds useful as pesticides | BENKO ZOLTAN L | 2006-03-23 | — | — | US | disclosed |
| EP-1572656-A2 | COMPOUNDS USEFUL AS PESTICIDES | Dow Agrosciences LLC (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004057960-A2 | COMPOUNDS USEFUL AS PESTICIDES | DOW AGROSCIENCES LLC (US) | 2004-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063741-A1 | Compounds useful as pesticides | DDT, ACHE, BCHE | SMN1; SMN2 1795/4885RAB9A 360/4885ALDH1A1 2675/4885 |
| US-20090318466-A1 | COMPOUNDS USEFUL AS PESTICIDES | DDT, ACHE, BCHE | SMN1; SMN2 1795/4885RAB9A 360/4885ALDH1A1 2675/4885 |
| US-20220089608-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | CDK6, CDK1, CDK3 | SMN1; SMN2 1955/4885RAB9A 2547/4885ALDH1A1 2921/4885 |
| US-20230357265-A1 | CDK Inhibitors And Their Use As Pharmaceuticals | CDK6, CDK1, CDK3 | SMN1; SMN2 1955/4885RAB9A 2547/4885ALDH1A1 2921/4885 |
| US-11685744-B2 | CDK inhibitors and their use as pharmaceuticals | CDK6, CDK1, CDK3 | SMN1; SMN2 1955/4885RAB9A 2547/4885ALDH1A1 2921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.